These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The importance of inflammatory mechanisms in Alzheimer disease. McGeer EG; McGeer PL Exp Gerontol; 1998 Aug; 33(5):371-8. PubMed ID: 9762518 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cell death in Alzheimer disease--immunopathology. McGeer PL; McGeer EG J Neural Transm Suppl; 1998; 54():159-66. PubMed ID: 9850924 [TBL] [Abstract][Full Text] [Related]
4. Inflammation and the degenerative diseases of aging. McGeer PL; McGeer EG Ann N Y Acad Sci; 2004 Dec; 1035():104-16. PubMed ID: 15681803 [TBL] [Abstract][Full Text] [Related]
10. The brain as a target for inflammatory processes and neuroprotective strategies. Skaper SD Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562 [TBL] [Abstract][Full Text] [Related]
11. The role of inflammation in Alzheimer's disease. Tuppo EE; Arias HR Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976 [TBL] [Abstract][Full Text] [Related]
12. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. Walker DG; Lue LF J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156 [TBL] [Abstract][Full Text] [Related]
13. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482 [TBL] [Abstract][Full Text] [Related]
14. Inflammation, the complement system and the diseases of aging. McGeer EG; Klegeris A; McGeer PL Neurobiol Aging; 2005 Dec; 26 Suppl 1():94-7. PubMed ID: 16198446 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotection from complement-mediated inflammatory damage. Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806 [TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964 [TBL] [Abstract][Full Text] [Related]
18. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide. Członkowska A; Kurkowska-Jastrzebska I; Członkowski A; Peter D; Stefano GB Med Sci Monit; 2002 Aug; 8(8):RA165-77. PubMed ID: 12165754 [TBL] [Abstract][Full Text] [Related]
19. Transgenic animal models of neurodegenerative diseases and their application to treatment development. Rockenstein E; Crews L; Masliah E Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376 [TBL] [Abstract][Full Text] [Related]
20. Interleukins, inflammation, and mechanisms of Alzheimer's disease. Weisman D; Hakimian E; Ho GJ Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]